European Healthcare Acquisition & Growth Company B.V.

As of December 31, 2023, European Healthcare Acquisition & Growth Company B.V. has 20.00M shares outstanding.

As of December 31, 2023, European Healthcare Acquisition & Growth Company B.V. maintains a current ratio of 1.14, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) stands at 24.00, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is negative at -183.13, pointing to unprofitable operations over the period.

These figures cover the twelve months ended December 31, 2023. That works out to an effective tax rate of 0.81, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

As of December 31, 2023, European Healthcare Acquisition & Growth Company B.V. has an Altman Z-Score of 0.23, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.